Avery Posey Discusses CAR T Cell Cancer Therapies

FromCRISPR Cuts

Start listening View podcast show

Avery Posey Discusses CAR T Cell Cancer Therapies

FromCRISPR Cuts

ratings:

Length:

25 minutes

Released:

Jan 24, 2019

Format:

Podcast episode

Description

Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer.

Released:

Jan 24, 2019

Format:

Podcast episode

Titles in the series (32)

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Skip carousel

CRISPR for Curious Minds by CRISPR Cuts
41 min listen
Alex Philippidis Reviews Trends in Biopharma & Biotech Market: Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise... by CRISPR Cuts
28 min listen
Knockout Cell Pools Are Simplifying CRISPR Experiments: Dr. Ania Wronski, Product Manager for the Engineered Cells portfolio at Synthego, discusses how their new engineered cells products are enabling CRISPR access to researchers worldwide. Learn about the different ways in which researchers use knockout cell... by CRISPR Cuts
21 min listen
Reed Kelso Strives to Enable CRISPR Access For All Scientists: Reed Kelso, Head of Cell Engineering Research and Applications at Synthego, is a bio-wizard. In this episode, Kevin & Minu catch up with Reed about his role at Synthego and the day-to-day operations at the fast paced start-up. Reed talks about the revolu... by CRISPR Cuts
16 min listen
CRISPR in Gene Drives: Experts Opine: Gene drives have frequently been in the news in the past few years. In this episode, we discuss what exactly gene drives are, their applications, and how scientists are ensuring that they are used responsibly. Tune in to hear what researchers Anna Buchma... by CRISPR Cuts
11 min listen
Avery Posey Discusses CAR T Cell Cancer Therapies: Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer. by CRISPR Cuts
25 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans: In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. by CRISPR Cuts
18 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
Improving Targeted Delivery to Enhance Personalized Medicine: Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public. by CRISPR Cuts
28 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials: TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. by CRISPR Cuts
24 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Dina Simkin Breaks Down Epilepsy Cell Modeling: Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked... by CRISPR Cuts
27 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen

More Episodes from CRISPR Cuts

Skip carousel

Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia: Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to... by CRISPR Cuts
33 min listen
Dina Simkin Breaks Down Epilepsy Cell Modeling: Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked... by CRISPR Cuts
27 min listen
Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers: Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat. by CRISPR Cuts
25 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials: TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. by CRISPR Cuts
24 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans: In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. by CRISPR Cuts
18 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen

Related podcast episodes

Skip carousel

Targeted Therapy for Non-Small Cell Lung Cancer with an EGFR Exon 20 Insertion: ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with... by Cancer.Net Podcast
25 min listen
Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer: Drs. Hope Rugo and Nancy Davidson discuss the next generation of endocrine therapy in hormone receptor-positive breast cancer – SERDs, SERMs, CERANs, and PROTACs – and challenges relating to the optimal sequence of therapeutic options. TRANSCRIPT... by ASCO Daily News
31 min listen
ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity: Drs. Hope Rugo and Sara Tolaney discuss the promise of antibody-drug conjugates (ADCs) in the treatment of breast cancer, highlighting key trials that shed light on matching the right ADC to the right patient in the right setting. They also explore... by ASCO Daily News
30 min listen
Molecular Testing for Early-Stage Non-Small Cell Lung Cancer, with Ryan Gentzler, MD; Xiuning Le, MD, PhD; Brendan Stiles, MD; and Vamsidhar Velcheti, MD, FACP, FCCP: ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals. The purpose of this podcast is to educate... by Cancer.Net Podcast
17 min listen
Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC: Adjuvant immunotherapy is a game-changer for early lung cancer, but it is not the best choice for every patient. Hosted by Dr. Rami Manochakian (Mayo Clinic), Drs. Karen Kelly (University of California Davis) and Howard West (City of Hope Cancer... by ASCO Education
31 min listen
Optimizing Novel Therapies and Surgery in Early-Stage NSCLC: Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of... by ASCO Daily News
32 min listen
Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update: An interview with Dr. Beverly Moy from Massachusetts General Hospital in Boston, MA, lead author on "Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO... by ASCO Guidelines
9 min listen
Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline: An interview with Dr. Manish Shah from New York Presbyterian Weill Cornell Medical Center on the ASCO Resource Stratified Guideline which covers treatment of patients with early-stage colorectal cancer. To read the full guideline go to The purpose of... by ASCO Guidelines
11 min listen
Treating previously undruggable diseases with Dr. Ian Taylor, CSO at Arvinas by From Lab to Launch by Qualio
30 min listen
DOTATE-PET-Scan in the Management of Pancreatic NET: In this episode of SurgOnc Today®, Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, is joinded by Dr. James R. Howe from the University of Iowa and Dr. Nadine Mallak from the Oregon Health and... by SurgOnc Today®
26 min listen
Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline: An interview with Dr. Tian Zhang from UT Southwester Medical Center in Dallas, TX, author on "Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline." Dr. Zhang reviews the guideline recommendations for the treatment and management... by ASCO Guidelines
12 min listen
Interview: Mika Newton and Dr Seun Omofoye: Dr. Seun Omofoye is a neurosurgeon who talks about the latest challenges and advancements in cancer. On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology. If you are a cancer patient and want to explore your... by Target: Cancer Podcast
26 min listen
Dr. Shyamal Patel, Radiation Oncologist at Dignity Health Cancer Institute [RO] by CXR Careers in Radiology
45 min listen
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline: An interview from Dr. Larissa A. Korde from the National Cancer Institute and Dr. Dawn L. Hershman from Columbia University on “Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.” This guideline... by ASCO Guidelines
16 min listen
Clinical Trials in Genitourinary Cancers: KEYLYNK-010, KEYNOTE-866, PDIGREE: ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with... by Cancer.Net Podcast
27 min listen
Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement: An interview with Dr. Megan E. Daly from the University of California, Davis on “Radiation Therapy for Small Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline.” An ASCO Expert Panel reviewed an ASTRO guideline on radiation... by ASCO Guidelines
8 min listen
Genomic revolution and its impact on prostate cancer care: Professor Ash Tewari talks about the genomics of prostate cancer and the implications for managing high risk disease. by Surgical Grand Rounds Lectures
42 min listen
Dr. Karim Fizazi on the PEACE-1 Trial & Improving Outcomes in mCSPC: Dr. Karim Fizazi, medical oncologist at Gustave Roussy and professor in Oncology at the University of Paris-Saclay in France, tells guest host, Neeraj Agarwal, editor-in-chief of ASCO Daily News and director of the Genitourinary Cancers Programs at... by ASCO Daily News
15 min listen
Treatment of Multiple Myeloma Guideline: An interview with Dr. Joe Mikhael from the City of Hope Cancer Center and International Myeloma Foundation on the ASCO and CCO joint clinical practice guideline. The guideline makes recommendations for patients who are transplantation eligible and... by ASCO Guidelines
7 min listen
What is the TAPUR (Targeted Agent and Profiling Utilization Registry) Study, with Richard Schilsky, MD, FACP, FASCO: ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals. The purpose of this podcast is to educate... by Cancer.Net Podcast
11 min listen
Metastatic Pancreatic Cancer Guideline Update: An interview with Dr. Davendra Sohal from the University of Cincinnati, and Dr. Daniel Laheru from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins on “Metastatic Pancreatic Cancer: ASCO Guideline Update." This update covers new... by ASCO Guidelines
7 min listen
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update: An interview with Dr. Fabrice André from Institute Gustave Roussy in Paris, France, and Dr. Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, NY, authors on “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage... by ASCO Guidelines
10 min listen
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2022.2 Part 1: Dr. Dwight Owen presents the first update to the ASCO living guideline on stage IV NSCLC without driver alterations. He reviews the new evidence identified by the panel along with the updated recommendation regarding the role of bevacizumab in... by ASCO Guidelines
8 min listen
Prostate Cancer Survivor Bryce Olson’s Message: “Sequence Me!” by WCG Talks Trials
24 min listen
Optimum Imaging Strategies for Advanced Prostate Cancer Guideline: An interview with Dr. Edouard Trabulsi from the Sidney Kimmel Medical College at Thomas Jefferson University on "Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline." This guideline outlines techniques available and provides... by ASCO Guidelines
9 min listen
Can Hyperbaric Oxygen Therapy Boost Health? An Interview with Shai Efrati by Making Sense of Science
65 min listen
PARP Inhibitors in the Management of Ovarian Cancer Guideline: An interview with Dr. William P. Tew from Memorial Sloan Kettering Cancer Center on “PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.” This guideline provides recommendations on the use of poly (ADP-ribose) polymerase... by ASCO Guidelines
17 min listen
Treatment of Metastatic Colorectal Cancer Guideline: An interview with Dr. Van Morris from The University of Texas MD Anderson Cancer Center in Houston, TX and Dr. Cathy Eng from Vanderbilt-Ingram Cancer Center in Nashville, TN, co-chairs on "Treatment of Metastatic Colorectal Cancer: ASCO Guideline."... by ASCO Guidelines
21 min listen
Ep. 11 Love What You Do- Career Inspiration with Dr. Cherie-Ann Nathan: In this episode, Dr. Cherie-Ann Nathan joins hosts Dr. Gopi Shah and Dr. Ashley Agan to discuss career inspiration and learning to thrive with an inspiring attitude. by BackTable ENT
49 min listen
Cancer Topics - ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline: ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline by ASCO Education
11 min listen

Discover this podcast and so much more

Avery Posey Discusses CAR T Cell Cancer Therapies

Avery Posey Discusses CAR T Cell Cancer Therapies

Description

Titles in the series (32)

More Episodes from CRISPR Cuts

Related podcast episodes